MEHREEN MANSOOR
Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Child & Adolescent Psychiatry LOUISVILLE, KY NPI 1093857955
Browse related groups: Allopathic & Osteopathic Physicians|Psychiatry & Neurology|Child & Adolescent Psychiatry KY Neurocrine BioSciences, Inc. All categories
General Payments — all program years on this page
$455.47
- Category: General Payments
- Program years: PY2021–2024
- Record count: 24
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $137.87 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $137.87 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Neurocrine BioSciences, Inc. | $35.39 | 2 |
| Noven Therapeutics, LLC | $34.53 | 2 |
| Janssen Pharmaceuticals, Inc | $31.22 | 2 |
| ITI, Inc. | $19.46 | 1 |
| Teva Pharmaceuticals USA, Inc. | $17.27 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1078027230 | Janssen Pharmaceuticals, Inc | $13.45 | 09/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1078027516 | Janssen Pharmaceuticals, Inc | $17.77 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1084823455 | Noven Therapeutics, LLC | $15.71 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1084823457 | Noven Therapeutics, LLC | $18.82 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1143270815 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $19.46 | 01/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150863233 | Neurocrine Biosciences, Inc. | $18.73 | 10/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1150870161 | Neurocrine Biosciences, Inc. | $16.66 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1151553692 | Teva Pharmaceuticals USA, Inc. | $17.27 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.